Enclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered. Kindly take the same on record.

SUPRIYA LIFESCIENCE LTD. " Creati11g true values that bind global l,ealtl, September 02, 2026 BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot no. C/1, G Block, Dalal Street, Bandra-Kurla Complex Mumbai- 400 001 Bandra (E), Mumbai - 400 051 Scrip Code: 543434 NSE Symbol: SUPRIYA Dear Sir (s), Sub: Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 In terms of Regulation 36(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has sent Letter providing the weblink of the exact address where the Annual Report is uploaded on the Website to those shareholders whose email ids are not registered with the Company / Depository/ MUFG Intime India Pvt. Ltd. (Company’s RTA). The same is available on the website of the Company at www.supriyalifescience.com under “Investor Section”. Kindly take the said information on your records. Thanking you, Yours faithfully, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE SUPRIYA LIFESCIENCE LTD. SUPRIYA LIFESCIENCE LIMITED CIN: L51900MH2008PLC180452 Registered Office: 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai -400063 Tel: +9191 22 4033 2727| E-mail: cs@supriyalifescience.com| Website: www.supriyalifescience.com Date: September 01, 2026 Dear Shareholder, Sub: Supriya Lifescience Limited–Annual Report for the Financial Year 2025-26 We are pleased to inform you that the 18thAnnual General Meeting (“AGM”) of the Members of Supriya LifescienceLimited (the “Company”) will be held on Thursday, September 24, 2026 at 3:00 P.M. (IST) through Video Con ferencing / Other Audio Visual Means („VC/OAVM‟) in compliance with the applicable provisions of the Companies Act, 2013 and Rules issued thereunder and the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations"), read with various circulars issued by the Ministry of Corporate Affairsfrom time to time. I n terms of Regulation 36 (1) (b) of the SEBI Listing Regulations, as amended, a communication containing the web-link providing the complete details of the path of theAnnual Report for the financial ye ar 2025-26 is being sent to those Member(s) whose email address(es) are not registered withthe Company/MUFG Intime India Priva te Limited, Registrar & Share Transfer Agent (“RTA”)of the Company/ their respective Depository Participant(s) ("DP"). You may access the soft copy of the Annual Report for the financial year 2025-26and th e Notice convening the 18thAGM b yvisiting on web link/path https://www.supriyalifescience.com/ir-annual-report-return.php The Annual Report of the Company, including the Notice of th e AGM, is also available on the website of stock exchange i.e. BSE Limited and National Stock Exchange of india Limited at www.bseindia.com, www.nseindia.comand also on the websiteof National Securities Depository Limited ("NSDL”) at www.evoting.nsdl.com. The Members are requested to register the email address with their re spective Depository Participant (in case of d emat h oldings) to receive all future communications electronically. This letter is being sent to those member(s) who have not registered their email address(es) either with the Company or with any Depository or RTA of the Company as on the cut-off date as on Friday, August21, 2026. F or any queries or further assistance, please reach out to the RTA at Investor.helpdesk@in.mpms.mufg.com Thank you for your continued support. Yours faithfully, ForSupriya LifescienceLimited Sd/- Prachi Sathe Company Secretary & Compliance Officer